Half-year report · Q2
7681.TEDINET S100VQVP
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥19.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥497m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥514m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥181m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥514m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥344m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥136m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥221m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥356m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥229m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥16.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥10.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥13.5bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.9bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.9bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥87m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥521m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥101m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥105m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥97m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥100m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥58.32 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.09 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.49 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥58.08 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.96 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.26 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 36.0% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥193m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥193m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥2m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥410m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥410m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥41m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥12.3bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥12.3bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥453m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥496m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥7m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥31m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥319m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥357m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中 田 明 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)安 田 秀 樹 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 12216679000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 12940317000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 19804248000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 357958000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 513837000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 181146000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 220708000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 344286000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 136057000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 249718000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 350933000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 112733000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 5874485000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 5988048000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 5741300000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 13527919000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 16144747000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 10659647000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 37.49 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 58.32 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 23.09 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 37.26 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 58.08 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 22.96 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.422 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.360 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.523 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 520815000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -87249000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 33083000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -22856000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -123328000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | 100752000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -99632000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -105444000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -97225000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 5915747000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 5238009000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 5554031000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5904000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5904000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 5904000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 5904000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 1995000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3379 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |